Cereno Scientific’s shares are now traded on Nasdaq First North Growth Market
Cereno Scientific (SSME: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced the commencement of trading in the company’s shares of Series B on Nasdaq First North.The shares of Series B will continue to be traded under the ticker CRNO B and ISIN code SE0008241558. No new shares will be issued in connection with the admission to trading on Nasdaq First North. The current shareholders in Cereno do not need to take any measures in connection with the marketplace change. “This is a pivotal day for the Cereno team, as we proudly